Search Results - "Tsai, F"
-
1
HLA‐Cw6 and psoriasis
Published in British journal of dermatology (1951) (01-04-2018)“…Summary Psoriasis is a multifactorial disease with a strong genetic background. HLA‐Cw6 is one of the most strongly associated psoriasis susceptibility…”
Get full text
Journal Article -
2
Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial
Published in British journal of dermatology (1951) (01-01-2018)“…Summary Background Guselkumab, an anti‐interleukin‐23 monoclonal antibody, has demonstrated significant efficacy in phase III psoriasis trials. Objectives To…”
Get full text
Journal Article -
3
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
Published in Annals of oncology (01-09-2013)“…Pertuzumab (P) combined with trastuzumab (H)-based chemotherapy improves efficacy in early and advanced HER2-positive breast cancer. We assessed the…”
Get full text
Journal Article -
4
Secukinumab 2‐weekly vs. 4‐weekly dosing in plaque‐type psoriasis
Published in British journal of dermatology (1951) (01-05-2021)“…Linked Article: Reich et al. Br J Dermatol 2021; 184:849–856…”
Get full text
Journal Article -
5
Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment
Published in British journal of dermatology (1951) (01-07-2020)“…Linked Article: Warren et al. Br J Dermatol 2020; 183:60–70…”
Get full text
Journal Article -
6
Tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: long‐term safety and efficacy in an open‐label extension study
Published in British journal of dermatology (1951) (01-10-2018)“…Summary Background Tofacitinib is an oral Janus kinase inhibitor. Final safety and efficacy data from an open‐label extension study of tofacitinib in psoriasis…”
Get full text
Journal Article -
7
-
8
Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series
Published in British journal of dermatology (1951) (01-06-2018)Get full text
Journal Article -
9
The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C
Published in British journal of dermatology (1951) (01-12-2013)“…Summary Background Ustekinumab, an interleukin (IL)‐12 and IL‐23 blocker, has emerged as a new therapeutic option for patients with psoriasis. It is generally…”
Get full text
Journal Article -
10
Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: a retrospective analysis
Published in British journal of dermatology (1951) (01-11-2014)“…Summary Background Ustekinumab, an interleukin‐12/23 inhibitor, is effective in the treatment of psoriasis. A recent Italian study showed more favourable…”
Get full text
Journal Article -
11
Older Adults’ Knowledge of Geriatric Depression and Its Related Factors
Published in European psychiatry (01-08-2024)“…IntroductionEven though depression is a severe health issue among older adults, few studies have explored their knowledge of geriatric…”
Get full text
Journal Article -
12
Effects of a transition care program on depression, self-efficacy, and self-care behaviors in heart failure patients
Published in European psychiatry (01-08-2024)“…IntroductionHeart failure is a progressive and unpredictable heart disease. How to work with these patients to decrease their psychological distress and…”
Get full text
Journal Article -
13
The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection
Published in British journal of dermatology (1951) (01-11-2012)“…Summary Background Ustekinumab is a monoclonal antibody that targets interleukin (IL)‐12/23 p40 to treat psoriasis. The IL‐12 pathway is also important in…”
Get full text
Journal Article -
14
Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study
Published in Molecular psychiatry (01-08-2018)“…A previous genetic study has suggested that schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder (ASD) and attention deficit…”
Get full text
Journal Article -
15
The role of β‐blockers in dermatological treatment: a review
Published in Journal of the European Academy of Dermatology and Venereology (01-03-2018)“…Many systemic medications have been used off‐label in cutaneous diseases. Use of β‐adrenergic‐blocking agents has risen in popularity among dermatologists…”
Get full text
Journal Article -
16
Juvenile‐onset pustular psoriasis: case series and literature review
Published in British journal of dermatology (1951) (01-03-2020)Get full text
Journal Article -
17
Estimated global incidence of Japanese encephalitis: a systematic review
Published in Bulletin of the World Health Organization (01-10-2011)“…To update the estimated global incidence of Japanese encephalitis (JE) using recent data for the purpose of guiding prevention and control efforts. Thirty-two…”
Get full text
Journal Article -
18
Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study
Published in British journal of dermatology (1951) (01-07-2015)“…Summary Background Few studies have examined the association between psoriasis and glomerulonephritis (GN) as well as chronic kidney disease (CKD). Objectives…”
Get full text
Journal Article -
19
Induction of ferroelectricity in nanoscale ZrO2/HfO2 bilayer thin films on Pt/Ti/SiO2/Si substrates
Published in Acta materialia (15-08-2016)“…Large ferroelectricity has been demonstrated in nanoscale bilayer thin films consisting of undoped ZrO2 and HfO2 layers on conventional Pt/Ti/SiO2/Si…”
Get full text
Journal Article -
20
Advanced Age and Increased Risk for Severe Outcomes of Dengue Infection, Taiwan, 2014-2015
Published in Emerging infectious diseases (01-08-2023)“…Dengue, a mosquitoborne flavivirus infection, is increasingly a disease of older adults who are more likely to have chronic diseases that confer risk for…”
Get full text
Journal Article